Papers
Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeksCommentary: Has hypericum found its place in antidepressant treatment?
BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7224.1534 (Published 11 December 1999) Cite this as: BMJ 1999;319:1534Data supplement
Sample size calculationThe sample size (100 in the active treatment groups and 40 in the placebo group) was estimated according to the following variables: primary endpoint change from baseline on Hamilton depression total score; assumption of improvement in the placebo group by nine points, improvement in the active drug groups by 12 points, and standard deviation of changes by 6 points; a minimum important difference for comparison between hypericum extract v placebo: d>0.5 (d is difference between both treatments divided by standard deviations; non-inferior difference for comparison between hypericum extract v imipramine: d£ 0.35; and α =0.025 (one sided), 1-β =0.80.
Flow of participants
Related articles
- This Week In The BMJ Published: 11 December 1999; BMJ 319 doi:10.1136/bmj.319.7224.0d
- Correction Published: 05 February 2000; BMJ 320 doi:
- Letter Published: 22 April 2000; BMJ 320 doi:10.1136/bmj.320.7242.1141/a
- Student Published: 01 October 2000; BMJ 321 doi:10.1136/sbmj.0010351
See more
- Return of the “firm” gets cautious welcomeBMJ December 07, 2016, 355 i6556; DOI: https://doi.org/10.1136/bmj.i6556
- Cancer drugs remain FDA approved despite lack of benefit, study findsBMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568
- Whole brain radiotherapy for brain metastasesBMJ December 05, 2016, 355 i6483; DOI: https://doi.org/10.1136/bmj.i6483
- Five thousand dead and counting: the Philippines’ bloody war on drugsBMJ November 28, 2016, 355 i6177; DOI: https://doi.org/10.1136/bmj.i6177
- Fair vaccine pricing please, not random acts of charityBMJ November 23, 2016, 355 i6173; DOI: https://doi.org/10.1136/bmj.i6173
Cited by...
- Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
- Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine
- St John's wort for depression: Meta-analysis of randomised controlled trials
- Mild depression in general practice: time for a rethink?
- The antidepressant debate
- Comparison of St John's wort and imipramine
- Advances in psychiatric treatment in primary care
- Can complementary medicine be evidence based?
- Comparison of St John's wort and imipramine for treating depression: randomised controlled trial
- Hypericum extract was better than placebo and equivalent to imipramine for moderate depression
- Hypericum extract was better than placebo and equivalent to imipramine for moderate depression
- The use of St John's Wort in the treatment of depression
- Use of hypericum as antidepressant
- St. John's Wort for Depression -- Again
- St. John's Wort vs. Imipramine for Moderate Depression
- St John's Wort Really Does Help Depression